Cape Investment Advisory’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$732K Buy
2,880
+201
+8% +$46.8K 0.2% 91
2026
Q1
$655K Sell
2,679
-139
-5% -$32.4K 0.22% 97
2025
Q4
$583K Buy
2,818
+2,029
+257% +$401K 0.18% 101
2025
Q3
$146K Sell
789
-2,055
-72% -$352K 0.14% 131
2025
Q2
$434K Sell
2,844
-1
-0% -$154 0.16% 109
2025
Q1
$472K Sell
2,845
-297
-9% -$46.5K 0.19% 93
2024
Q4
$454K Sell
3,142
-823
-21% -$128K 0.18% 94
2024
Q3
$643K Sell
3,965
-92
-2% -$14.7K 0.26% 73
2024
Q2
$593K Sell
4,057
-556
-12% -$82.7K 0.27% 73
2024
Q1
$730K Sell
4,613
-156
-3% -$24.8K 0.34% 66
2023
Q4
$748K Buy
4,769
+307
+7% +$47.1K 0.37% 57
2023
Q3
$695K Sell
4,462
-1,194
-21% -$197K 0.39% 54
2023
Q2
$936K Buy
5,656
+276
+5% +$44.5K 0.52% 42
2023
Q1
$834K Buy
+5,380
New +$869K 0.51% 43

Other funds holding JNJ

Cape Investment Advisory's JNJ Position: Q2 2026 in Review

Cape Investment Advisory increased its Johnson & Johnson (JNJ) stake by 7.5% in Q2 2026, buying an estimated $46.8K and bringing the position to 2,880 shares worth $732K. The position accounts for 0.2% of the portfolio, ranked #91.

Cape Investment Advisory first reported a position in JNJ in Q1 2023 and has held it in 14 quarters since. The position peaked at $936K in Q2 2023. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Cape Investment Advisory held 2,880 shares of Johnson & Johnson worth $732K as of Q2 2026.
  • Cape Investment Advisory bought 201 Johnson & Johnson shares in Q2 2026, an estimated $46.8K.
  • Johnson & Johnson made up 0.2% of Cape Investment Advisory's portfolio in Q2 2026, its #91 holding.
  • Cape Investment Advisory first reported a position in Johnson & Johnson in Q1 2023 and has held it in 14 quarters since.
  • Cape Investment Advisory's Johnson & Johnson position peaked at $936K in Q2 2023.
  • 4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Cape Investment Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.